KIR2DL4 and renal cell carcinoma: Another interesting finding claimed that KIR2DL4 was also highly expressed in RCC cells, which promotes RCC progression through phosphatidylinositol-3-kinase (PI3K)/protein kinase B (AKT) activation (Ding et al., 2022).